Creative Realities Projects Positive Q2 Adjusted EBITDA and Revenue, Commences Public Offering
CREX sits 51% above its 52-week low of $2.187 on elevated volume (2.1× avg).
Summary
Creative Realities announced preliminary Q2 2026 estimates showing positive Adjusted EBITDA and strong revenue, a significant improvement following a 'going concern' warning and negative Q1 results, while also commencing a public offering to raise capital.
Key Events · Earnings and Guidance · CREX
-
Preliminary Q2 2026 Financial Estimates
The company expects unaudited revenue for Q2 2026 to be between $21.0 million and $23.0 million, with Adjusted EBITDA projected in the range of $2.0 million to $2.2 million, reflecting an approximate 10.0% margin. This follows a Q1 2026 with negative Adjusted EBITDA and a 'going concern' warning.
-
Commencement of Public Offering
Creative Realities has commenced an underwritten public offering of common stock and pre-funded warrants, with an option for the underwriter to purchase an additional 12.5%. The net proceeds are intended for working capital, general corporate purposes, debt paydown, and potential acquisitions, building on the previously filed $100 million universal shelf registration.
Analysis · CREX · Technology
This filing is highly important as Creative Realities, a company previously operating under a 'going concern' warning and reporting negative Adjusted EBITDA in Q1 2026, now projects positive Adjusted EBITDA and solid revenue for Q2 2026. This preliminary financial improvement is a critical positive signal, suggesting a potential turnaround in operational performance. Concurrently, the company has commenced a public offering of common stock and pre-funded warrants, which is a necessary step to secure working capital, pay down debt, and fund general corporate purposes, especially given its prior financial challenges. The positive preliminary earnings could make this capital raise more favorable.
At the time of this filing, CREX was trading at $3.30 on NASDAQ in the Technology sector, with a market capitalization of approximately $43.3M. The 52-week trading range was $2.19 to $4.42. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.